Headlines

MedPro Safety Products Introduces Pre-filled Safety Syringe


Product to be Featured at APIC Conference

Lexington, KY – June 28, 2011 – MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, today announced the introduction of its pre-filled safety syringe (PFSS). The device contains a precise dose of pharmaceutical stored within a syringe system equipped with MedPro’s unique, fully passive safety mechanism that reduces and potentially eliminates the risk of needlestick injury.

Pre-filled syringes represent an approximately 2.6 billion unit annual market growing at approximately 14% (Pre-filled Syringes, Greystone Associates, February 2008).  There is no fully passive pre-filled safety syringe currently commercially available in the U.S. and the MedPro product represents the first truly passive market entry.  Current estimates indicate that only 15% of the pre-filled market segment has converted to any type of safety solution.

The PFSS is comprised of two unique parts: (a) a standard glass or plastic cartridge that will act as both a pre-filled medicament reservoir and syringe plunger, and (b) a plastic safety syringe that incorporates a fully passive (or automatic) safety deployment system. The PFSS device offers significant benefits to healthcare safety, both for the patient and the healthcare professional. The automatic activation of a safety shield as a needle is removed protects the operator from the contaminated needle and prevents a needlestick injury.  The shield also reduces the chance of blood or drug splatter.  The prefilled cartridge offers patient safety through exact dosage control and the theoretical reduction of medicine delivery errors.  It also saves time in drug preparation and delivery.  The PFSS is designed to be compatible with existing pharmaceutical filling technology for ease of adoption and operational efficiencies, and the glass cartridge is consistent with current industry standards.

“The pre-filled safety syringe is another example of the Company’s strategy to expand our unique patented passive safety technology across platforms,” said Craig Turner, CEO of MedPro Safety Products.  “The PFSS can deliver a wide range of biotech and pharmaceutical products.  We are currently in various stages of discussions with several potential partners to explore the commercialization of the PFSS in several markets and we will be featuring this exciting product at the APIC trade show in Baltimore June 27-29.”

About MedPro Safety Products, Inc.

Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. is a leading developer of safer medication delivery and blood collection systems.  The Company licenses, develops and manufactures transformational technologies marketed through its global medical device partners.  MedPro’s portfolio addresses multiple product categories within the medical delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) markets.  These products incorporate needlestick prevention features considered to be the most passive now available on the market as they require little or no clinician training compared to competitive products.  The total global market opportunity currently addressed by the Company’s products is estimated to be in excess of $6 billion.  For additional information, please refer to the ‘Investor Relations’ link on MedPro’s website (http://www.medprosafety.com).

Safe Harbor Statement

This release includes forward-looking statements based upon current expectations of the management of MedPro Safety Products, Inc. that involve risks and uncertainties, such as plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward- looking statements as a result of a number of factors, including our ability to identify and acquire medical safety device safety technologies with product development potential; our ability to successfully develop and bring products to market, including obtaining regulatory approvals; our ability to successfully increase sales of our products; our ability to obtain additional financing on satisfactory terms; our ability to attract and retain qualified employees; and governmental regulation associated with the medical safety products industry. Words such as "anticipate," "estimate," "plan," "continuing," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could," and similar expressions are used to identify forward-looking statements. We refer you to the more detailed discussion of risks and uncertainties under "Risk Factors" in our Annual Report on Form 10-K and our other reports on file with the Securities and Exchange Commission.


Contact Information:

Investor Contact:

Doug Sherk/Jenifer Kirtland

EVC Group

415-568-4887

 
Media Contact:

Steve DiMattia

EVC Group

646-201-5445